Feasibility of tumor-informed circulating tumor DNA for detecting minimal residual disease in surgically resected biliary tract cancer. Park Y, Kim KS, Jo H, Kim HP, et al. PLoS One 2026;21:e0341432.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Park Y, Kim KS, Jo H, Kim HP, et al. Feasibility of tumor-informed circulating tumor DNA for detecting minimal residual disease in surgically resected biliary tract cancer. PLoS One 2026;21:e0341432.
PMID: 41563984